Skip to main content
. 2022 Mar 27;9(3):1524–1541. doi: 10.1002/ehf2.13884

Figure 4.

Figure 4

Overview of the frequency of diagnostic tool combinations suggested in the 50 articles included for review. The category ‘Biopsy after inconclusive results from a bone scintigraphy and/or monoclonal protein test’ consists of diagnostic pathways suggesting one or more of the following to diagnose ATTRwt CM: (i) bone scintigraphy grade 2–3, positive monoclonal protein test, and biopsy; (ii) bone scintigraphy grade 0/1, positive monoclonal protein test, and biopsy; and (iii) bone scintigraphy grade 0/1, negative monoclonal protein test, and biopsy.